Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
883.2 DKK | +0.07% | -1.62% | +26.51% |
02:47pm | Novo Nordisk Enters Research Partnership for New Weight Loss Drugs | MT |
02:34pm | Novo Nordisk May Pay Up to $600 Million in New Obesity R&D Deal | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.51% | 568B | |
+33.74% | 698B | |
-4.98% | 358B | |
+18.76% | 328B | |
+3.45% | 283B | |
+15.87% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+7.04% | 165B | |
-4.25% | 160B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- INTERVIEW - Lars Fruergaard Jorgensen, CEO of Novo Nordisk: Treating obesity will be one of our top healthcare priorities